跳至主要内容
临床试验/NCT01865240
NCT01865240终止4 期

Renal Denervation for Resistant Hypertension

Baker Heart and Diabetes Institute2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2012年2月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
入组人数
5
试验地点
2
主要终点
blood pressure control

研究概览

简要总结

This is a study investigating the effectiveness of renal denervation in lowering blood pressure in people whose blood pressure is not adequately controlled despite treatment with 3 or more blood pressure lowering drugs. The study is designed to compare the effects of renal denervation to a usual care group receiving additional blood pressure lowering drugs.

详细描述

Previous studies have shown that the renal denervation procedure is safe and effective in reducing blood pressure in patients with resistant hypertension. A total of 100 participants with uncontrolled blood pressure, treated with three or more blood pressure lowering medications will be recruited into the study. Patients will be assigned to one (1) of two (2) groups with the aim of attaining blood pressure control. Participants in group 1 will be assigned to renal denervation, participants in group 2 will receive additional antihypertensive medication according to current guidelines and best practice in an attempt to reach blood pressure targets.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • systolic BP ≥140mmHg or ≥130mmHg for patients with diabetes
  • concurrent treatment with ≥3 anti-hypertensive drugs

排除标准

  • renal artery anatomy ineligible for treatment
  • eGFR <15mL/min/1.73m2 (using Modification of Diet in Renal Disease (MDRD) calculation)
  • female participants of childbearing potential must have negative pregnancy test prior to treatment

研究组 & 干预措施

Renal Denervation Group

Experimental

participants randomised to undergo the renal denervation procedure

干预措施: Renal Denervation (Device)

Usual care

No Intervention

participants randomised to the usual care group will receive additional antihypertensive medication in an attempt to achieve blood pressure targets

结局指标

主要结局

blood pressure control

时间窗: 6 months post procedure

percentage of patients to achieve Blood Pressure (BP) target (BP \<140/90mmHg, or \<130/80mmHg in diabetic patients) at 6 months post procedure

次要结局

  • number of drugs required to reach blood pressure target(baseline to 6 months)
  • Change in Left Ventricular Structure and Function(baseline to 6 months)
  • Change in Quality of Life(baseline to 6 months)
  • Serum and Urine Biochemistry(baseline to 6 months)
  • Change in markers of arterial stiffness(baseline to 6 months)
  • time to achieve blood pressure target(baseline to 6 months)
  • Change in markers of sympathetic nerve activity(baseline to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验